Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PlexoZome Levagen
- Development stage
- Unknown
- Lead developer
- Pharmako Biotechnologies
- Modality
- Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Small Molecules
- Administration
- Topical
01
Overview
PlexoZome Levagen is a **topical spray formulation containing palmitoylethanolamide (PEA) delivered via liposomal technology** (PlexoZome®), designed for enhanced bioavailability and targeted delivery[4][5][2][7]. PEA is an endogenous fatty acid amide with scientifically established **anti-inflammatory, analgesic, and immune-modulating effects**[5][3][7]. The liposomal PlexoZome technology provides genuine, customizable liposome encapsulation for PEA to increase stability, skin penetration, and efficacy[4][2]. The primary indication is for **relief of joint and muscle pain, including post-exercise knee pain and arthritis**[1][5][7]. Clinical trials show the spray achieves faster and more effective pain reduction versus placebo, with no significant adverse effects reported[5][7]. Developed and manufactured in Australia, the product benefits from advanced delivery system research[6].
- Brand names
- PlexoZome Levagen
- Other names
- PlexoZome LevagenPlexoZomeLevagenLevagen+palmitoylethanolamide liposomal spray
02
Targets
CNR2 (Cannabinoid receptor type 2)TRPV1 (Transient receptor potential cation channel subfamily V member 1)FAAHPPARA (Peroxisome proliferator-activated receptor alpha)GPR55 (G protein-coupled receptor 55)
Beyond the preview
Go deeper on PlexoZome Levagen.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PlexoZome Levagen.